Product Description

Approved by FDA under NADA# 141-539. Approved for replacement therapy for diminished thyroid function in dogs. ThyroKare (levothyroxine sodium tablets) meets all USP standards, FDA-USP collaboration is essential to ensure appropriate quality standards and, where applicable, standards that reflect FDA approved product quality standards. ThyroKare is offered in 9 strengths from 0.1mg to 1.0mg in 0.1mg increments. ThyroKare is offered in 180 count and 1000 count bottles to meet specific prescription quantity needs. Federal law restricts this drug to use by or on the order of a licensed veterinarian.

Features & Benefits

• Approved for replacement therapy for diminished thyroid function in dogs
• Approved by the FDA (NADA# 141-539)
• Offered in 9 different strengths from 0.1mg to 1.0mg in 0.1mg increments
• Offered in 180 and 1000 count bottles to meet specific prescription quantity needs
• Meets all USP standards
• Made in the USA